BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7517205)

  • 1. Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cells.
    Wojta J; Nakamura T; Fabry A; Hufnagl P; Beckmann R; McGrath K; Binder BR
    Blood; 1994 Jul; 84(1):151-7. PubMed ID: 7517205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.
    Wojta J; Kaun C; Breuss JM; Koshelnick Y; Beckmann R; Hattey E; Mildner M; Weninger W; Nakamura T; Tschachler E; Binder BR
    Lab Invest; 1999 Apr; 79(4):427-38. PubMed ID: 10211995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
    Paciucci R; Vilá MR; Adell T; Díaz VM; Torà M; Nakamura T; Real FX
    Am J Pathol; 1998 Jul; 153(1):201-12. PubMed ID: 9665481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells.
    Morton PA; Owensby DA; Wun TC; Billadello JJ; Schwartz AL
    J Biol Chem; 1990 Aug; 265(24):14093-9. PubMed ID: 2167306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells.
    Pepper MS; Matsumoto K; Nakamura T; Orci L; Montesano R
    J Biol Chem; 1992 Oct; 267(28):20493-6. PubMed ID: 1328201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
    Imagawa S; Fujii S; Dong J; Furumoto T; Kaneko T; Zaman T; Satoh Y; Tsutsui H; Sobel BE
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2407-13. PubMed ID: 16902162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators.
    Sitter T; Toet K; Fricke H; Schiffl H; Held E; Kooistra T
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1256-63. PubMed ID: 8945961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
    Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
    Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1.
    Morton PA; Owensby DA; Sobel BE; Schwartz AL
    J Biol Chem; 1989 May; 264(13):7228-35. PubMed ID: 2540181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-4 stimulates expression of urokinase-type-plasminogen activator in cultured human foreskin microvascular endothelial cells.
    Wojta J; Gallicchio M; Zoellner H; Filonzi EL; Hamilton JA; McGrath K
    Blood; 1993 Jun; 81(12):3285-92. PubMed ID: 8507866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
    Sitter T; Toet K; Quax P; Kooistra T
    Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2.
    Owensby DA; Morton PA; Schwartz AL
    J Biol Chem; 1989 Oct; 264(30):18180-7. PubMed ID: 2553701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).
    Hall CL; Tsan R; Mugnai G; Mazar A; Radinsky R; Pettaway CA
    Prostate; 2004 May; 59(2):167-76. PubMed ID: 15042617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
    Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
    Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anisodamine counteracts lipopolysaccharide-induced tissue factor and plasminogen activator inhibitor-1 expression in human endothelial cells: contribution of the NF-kappa b pathway.
    Ruan QR; Zhang WJ; Hufnagl P; Kaun C; Binder BR; Wojta J
    J Vasc Res; 2001; 38(1):13-9. PubMed ID: 11173990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells.
    Bu G; Maksymovitch EA; Schwartz AL
    J Biol Chem; 1993 Jun; 268(17):13002-9. PubMed ID: 8389767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.
    Colucci M; Gesualdo L; Montemurro P; Cavallo LG; Conese M; Mascolo E; Ranieri E; Di Paolo S; Schena FP; Semeraro N
    Thromb Haemost; 1995 Dec; 74(6):1516-20. PubMed ID: 8772230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells.
    Gesualdo L; Ranieri E; Monno R; Rossiello MR; Colucci M; Semeraro N; Grandaliano G; Schena FP; Ursi M; Cerullo G
    Kidney Int; 1999 Aug; 56(2):461-70. PubMed ID: 10432384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis.
    Montemurro P; Barbuti G; Conese M; Gabriele S; Petio M; Colucci M; Semeraro N
    Br J Haematol; 1999 Nov; 107(2):294-9. PubMed ID: 10583214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.